<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Internet Res</journal-id><journal-id journal-id-type="iso-abbrev">J. Med. Internet Res</journal-id><journal-id journal-id-type="publisher-id">JMIR</journal-id><journal-title-group><journal-title>Journal of Medical Internet Research</journal-title></journal-title-group><issn pub-type="ppub">1439-4456</issn><issn pub-type="epub">1438-8871</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29258973</article-id><article-id pub-id-type="pmc">5750422</article-id><article-id pub-id-type="publisher-id">v19i12e413</article-id><article-id pub-id-type="doi">10.2196/jmir.8330</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group><subj-group subj-group-type="article-type"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Two-Way Social Media Messaging in Postoperative Cataract Surgical Patients: Prospective Interventional Study</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Parra-Calder&#x000f3;n</surname><given-names>Carlos Luis</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Jo</surname><given-names>Youngji</given-names></name></contrib><contrib contrib-type="reviewer"><name><surname>Musiimenta</surname><given-names>Angella</given-names></name></contrib></contrib-group><contrib-group><contrib id="contrib1" contrib-type="author"><name><surname>Sanguansak</surname><given-names>Thuss</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4737-5574</contrib-id></contrib><contrib id="contrib2" contrib-type="author" corresp="yes"><name><surname>Morley</surname><given-names>Katharine E</given-names></name><degrees>MPH, MD</degrees><xref ref-type="aff" rid="aff2">2</xref><address><institution>Department of Medicine</institution><institution>Massachusetts General Hospital</institution><addr-line>108 Parkman St</addr-line><addr-line>Boston, MA, 02114</addr-line><country>United States</country><phone>1 617 726 2707</phone><fax>1 617 724 0189</fax><email>kemorley@mgh.harvard.edu</email></address><xref ref-type="aff" rid="aff3">3</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2286-2253</contrib-id></contrib><contrib id="contrib3" contrib-type="author"><name><surname>Morley</surname><given-names>Michael G</given-names></name><degrees>ScM, MD</degrees><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6373-7008</contrib-id></contrib><contrib id="contrib4" contrib-type="author"><name><surname>Thinkhamrop</surname><given-names>Kavin</given-names></name><degrees>DrPH</degrees><xref ref-type="aff" rid="aff5">5</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2727-2925</contrib-id></contrib><contrib id="contrib5" contrib-type="author"><name><surname>Thuanman</surname><given-names>Jaruwan</given-names></name><degrees>MPH</degrees><xref ref-type="aff" rid="aff5">5</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6797-602X</contrib-id></contrib><contrib id="contrib6" contrib-type="author"><name><surname>Agarwal</surname><given-names>Isha</given-names></name><degrees>ScD, MD</degrees><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6979-5660</contrib-id></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Department of Ophthalmology</institution>
<institution>Faculty of Medicine</institution>
<institution>Khon Kaen University</institution>
<addr-line>Khon Kaen</addr-line>
<country>Thailand</country></aff><aff id="aff2">
<sup>2</sup>
<institution>Department of Medicine</institution>
<institution>Massachusetts General Hospital</institution>
<addr-line>Boston, MA</addr-line>
<country>United States</country></aff><aff id="aff3">
<sup>3</sup>
<institution>Harvard Medical School</institution>
<addr-line>Boston, MA</addr-line>
<country>United States</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Ophthalmic Consultants of Boston</institution>
<institution>Department of Ophthalmology</institution>
<institution>Harvard Medical School</institution>
<addr-line>Boston, MA</addr-line>
<country>United States</country></aff><aff id="aff5">
<sup>5</sup>
<institution>Data Management and Statistical Analysis Center</institution>
<institution>Faculty of Public Health</institution>
<institution>Khon Kaen University</institution>
<addr-line>Khon Kaen</addr-line>
<country>Thailand</country></aff><aff id="aff6">
<sup>6</sup>
<institution>Harvard School of Public Health</institution>
<addr-line>Boston, MA</addr-line>
<country>United States</country>
</aff><author-notes><corresp>Corresponding Author: Katharine E Morley
<email>kemorley@mgh.harvard.edu</email></corresp></author-notes><pub-date pub-type="collection"><month>12</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>19</day><month>12</month><year>2017</year></pub-date><volume>19</volume><issue>12</issue><elocation-id>e413</elocation-id><history><date date-type="received"><day>1</day><month>7</month><year>2017</year></date><date date-type="rev-request"><day>11</day><month>9</month><year>2017</year></date><date date-type="rev-recd"><day>6</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>7</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9;Thuss Sanguansak, Katharine E Morley, Michael G Morley, Kavin Thinkhamrop, Jaruwan Thuanman, Isha Agarwal. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 19.12.2017.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p><!--CREATIVE COMMONS-->This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="http://www.jmir.org/,">http://www.jmir.org/,</ext-link> as well as this copyright and license information must be included.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="http://www.jmir.org/2017/12/e413/"/><abstract><sec sec-type="background"><title>Background</title><p>Social media offers a new way to provide education, reminders, and support for patients with a variety of health conditions. Most of these interventions use one-way, provider-patient communication. Incorporating social media tools to improve postoperative (postop) education and follow-up care has only been used in limited situations.</p></sec><sec sec-type="objective"><title>Objective</title><p>The aim of this study was to determine the feasibility and efficacy of two-way social media messaging to deliver reminders and educational information about postop care to cataract patients.</p></sec><sec sec-type="methods"><title>Methods</title><p>A total of 98 patients undergoing their first eye cataract surgery were divided into two groups: a no message group receiving usual pre- and postop care and a message group receiving usual care plus messages in a mobile social media format with standardized content and timing. Each patient in the message group received nine messages about hand and face hygiene, medication and postop visit adherence, and links to patient education videos about postop care. Patients could respond to messages as desired. Main outcome measures included medication adherence, postop visit adherence, clinical outcomes, and patients&#x02019; subjective assessments of two-way messaging. The number, types, content, and timing of responses by patients to messages were recorded.</p></sec><sec sec-type="results"><title>Results</title><p>Medication adherence was better in the message group at postop day 7, with high adherence in 47 patients (96%, 47/49) versus 36 patients (73%, 36/49) in the no message group (<italic>P</italic>=.004), but no statistically significant differences in medication adherence between the groups were noted at preop and postop day 30. Visit adherence was higher at postop day 30 in the message group (100%, 49/49) versus the no message group (88%, 43/49; <italic>P</italic>=.03) but was 100% (49/49) in both groups at postop day 1 and 7. Final visual outcomes were similar between groups. A total of 441 standardized messages were sent to the message group. Out of 270 responses generated, 188 (70%) were simple acknowledgments or &#x0201c;thank you,&#x0201d; and 82 (30%) responses were questions that were divided into three general categories: administrative, postop care, and clinical issues. Out of the 82 question responses, 31 (11%) were about administrative issues, 28 (10%) about postop care, and 23 (9%) about clinical symptoms. All the messages about symptoms were triaged by nurses or ophthalmologists and only required reassurance or information. Patients expressed satisfaction with messaging.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Two-way social media messaging to deliver postop information to cataract patients is feasible and improves early medication compliance. Further design improvements can streamline work flow to optimize efficiency and patient satisfaction.</p></sec></abstract><kwd-group><kwd>cataract</kwd><kwd>social media</kwd><kwd>postoperative care</kwd><kwd>medication adherence</kwd></kwd-group></article-meta></front><body><sec sec-type="introduction"><title>Introduction</title><sec><title>Background and Rationale</title><p>Social media platforms on mobile phones have changed the way the world communicates. Medicine as a profession is beginning to embrace these new communication modalities to improve health care delivery. This opportunity is valuable in both high income countries as a means for improving patient engagement and education and in low- and middle-income countries where the limitations of overburdened clinics and staff, transportation barriers, and health literacy issues are challenges to providing health care.</p><p>Many mobile health (mHealth) interventions have been studied, including apps to enhance patient education, promote behavior change, and improve medication and visit adherence. Others are directed to improving health care delivery systems through electronic decision support, data sensors, data collection, patient tracking, and electronic health records [<xref rid="ref1" ref-type="bibr">1</xref>]. There is a growing body of research supporting the use of texting to improve patient follow-up [<xref rid="ref2" ref-type="bibr">2</xref>-<xref rid="ref4" ref-type="bibr">4</xref>] and medication adherence in chronic diseases such as HIV, tuberculosis, and hypertension [<xref rid="ref5" ref-type="bibr">5</xref>-<xref rid="ref10" ref-type="bibr">10</xref>]. Surgical specialties are starting to utilize mHealth technology to improve postop care. Armstrong et al [<xref rid="ref11" ref-type="bibr">11</xref>] showed a significant decrease in in-person follow-up visits and higher patient convenience scores after breast reconstructive surgery in patients using a mobile app for follow-up using photos and responses to validated recovery and pain surveys. Semple et al [<xref rid="ref12" ref-type="bibr">12</xref>] also used photos and validated quality of recovery questionnaires for postop follow-up of breast reconstruction and orthopedic surgical patients demonstrating feasibility and acceptability. In both of these studies, surgeons monitored questionnaires and photos and contacted patients based on this information. Another study in China used a social messaging app (WeChat) for follow-up of head and neck surgical patients in China that was shown to decrease patients lost to follow-up, improve patient satisfaction, save physicians&#x02019; time, and be more cost-effective compared with usual care [<xref rid="ref13" ref-type="bibr">13</xref>]. This study allowed for patient-initiated contact through the messaging app for questions.</p><p>mHealth interventions to enhance patient adherence have been used in ophthalmology. Some specific examples include medication adherence in glaucoma [<xref rid="ref14" ref-type="bibr">14</xref>], general outpatient clinic visit adherence [<xref rid="ref15" ref-type="bibr">15</xref>,<xref rid="ref16" ref-type="bibr">16</xref>], and postsurgical follow-up for pediatric cataract [<xref rid="ref17" ref-type="bibr">17</xref>] and trabeculoplasty [<xref rid="ref18" ref-type="bibr">18</xref>]. Cataract surgery has not yet been impacted by social media and messaging apps. This may be related to the lower use of these platforms in elderly populations with vision problems, but that is starting to change as patients, even older ones, increasingly use and rely on this technology [<xref rid="ref19" ref-type="bibr">19</xref>]. In low- and middle-income countries, improving outcomes for cataract surgery requires better patient education, compliance with medications, postop follow-up, and outcome monitoring [<xref rid="ref20" ref-type="bibr">20</xref>,<xref rid="ref21" ref-type="bibr">21</xref>]. mHealth technology and use of social media platforms are potential ways to help address these gaps.</p></sec><sec><title>Specific Aim</title><p>The specific aim of this research project was to determine the feasibility and efficacy of two-way social media messaging in postop cataract surgery patients. We hypothesize that redesigning patient communication and education regarding cataract surgery postop care using a mobile messaging app is feasible and can positively impact the quality and patient experience of postop cataract surgical care.</p></sec></sec><sec sec-type="methods"><title>Methods</title><sec><title>Setting</title><p>Patients were recruited from the ophthalmology clinic at Srinagarind Hospital, the academic teaching hospital for the Faculty of Medicine at Khon Kaen University and the main tertiary referral center for northeast Thailand. Khon Kaen is the largest city in northeast Thailand with a growing urban population and economy. The surrounding provinces, from which most patients come, are rural, agricultural-based, and less developed. Smartphones are widely available in Khon Kaen and surrounding provinces, with mobile apps being a primary mode of communication. In Thailand, SMS text messaging (short message service, SMS) is relatively expensive and not commonly used; messaging apps such as LINE are the preferred mode of communication.</p></sec><sec><title>Study Design</title><p>This is an interventional study with two groups. The control group received standard pre- and postcataract surgical care and education and included watching four educational videos on pre- and postop care in the clinic. The intervention group received standard pre- and postcataract surgical care and education, plus nine messages with standardized content and delivery schedule using the LINE messaging app (<xref ref-type="app" rid="app1">Multimedia Appendix 1</xref>). Message content included information about hand and face hygiene, medication instillation and adherence, visit reminders and adherence, medication reminders, and medication tapering schedule. Patients received a link to the same clinic educational videos on YouTube describing the preop and postop eye care and use of drops so they could watch them on demand (<xref ref-type="app" rid="app2">Multimedia Appendices 2</xref>-<xref ref-type="app" rid="app5">5</xref>).</p><p>Measurements of medication adherence, visit compliance, and clinical outcomes were obtained at the preop visit, postop day 7, and postop day 30 and compared between the two groups. The other study outcomes focused on the implementation and user experience of the LINE message group and included the number, type, content, and timing of the patient responses to messages. Clinical outcomes were measured, including visual acuity, intraocular pressure, and intraocular inflammation. Patients in the message group also completed a survey regarding subjective assessment of the message content and frequency (<xref ref-type="app" rid="app6">Multimedia Appendix 6</xref>).</p><p>The LINE social media messaging app was selected for this study because it is the most widely used mobile messaging app in the region, is free, has end-to-end encryption for one-to-one chats, automatic deletion from the server after set time, privacy settings to prevent sharing, allows for video links, and the LINE chat history could be downloaded for analysis after the study period.</p></sec><sec><title>Participant Recruitment</title><p>Patients recommended to have cataract surgery at the outpatient ophthalmology department at Srinagarind Hospital, Khon Kaen University who met the eligibility criteria were recruited for the study. Recruitment of patients was done in a before and after fashion, recruiting 49 patients for the nonintervention group first, followed by 49 patients in the intervention. This form of patient recruitment was employed to minimize the patient groups from comingling and discussing study-related variables, clinical care, or messages. Patients were eligible for participation in the study if they (1) did not have previous cataract or other eye surgery, (2) had access (directly or through surrogate) to a smartphone and successfully demonstrated facility using the LINE app to send or receive messages and view videos, (3) agreed to follow security settings for LINE study communication, (4) agreed to maintain mobile phone or data service or Wi-Fi service, and (5) agreed to notify the study coordinator if their mobile phone number changed. Patients were excluded if they could not fulfill the above criteria, were younger than 18 years, or were from vulnerable populations including prisoners, those with mental illness, and pregnant women.</p><p>Patients in the intervention group could elect to have the messages sent to themselves or a designated surrogate who took responsibility to inform the patient of the messages. Surrogates were direct family members (usually son or daughter) living in the same house. The reasons for using a surrogate typically related to older patients&#x02019; lack of familiarity with smartphone usage or visual impairment from cataract preventing screen visualization.</p></sec><sec><title>Study Variables</title><p>The study variables collected in the nonmessage and message groups included smartphone user (patient or surrogate), medication adherence scores, visit adherence, and clinical outcomes. Additional information collected from the message group included the number of responses by each patient to each message, types of responses to messages, types of questions sent, timing of responses, and patient feedback survey scores.</p><p>Medication adherence was measured with an officially validated Thai translation of the 8-item Morisky Medication Adherence Scale (MMAS-8; <xref ref-type="app" rid="app7">Multimedia Appendix 7</xref>) [<xref rid="ref22" ref-type="bibr">22</xref>]. Thai translation was performed by Mapi, an independent linguistic institution that provides validated translations of the MMAS-8, and reviewed by linguists at Khon Kaen University. Similar versions have been used in Thailand in studies of medication adherence in diabetes, HIV, and renal disease [<xref rid="ref23" ref-type="bibr">23</xref>-<xref rid="ref25" ref-type="bibr">25</xref>]. MMAS-8 is a widely used tool in the United States and other countries to evaluate medication adherence [<xref rid="ref26" ref-type="bibr">26</xref>]. Patients in the intervention and control groups completed the MMAS-8 at the preop visit to assess their baseline medication adherence behavior and then at POD-7 (postop day 7) and at POD-30 (postop day 30) visits. Patients were given a score of low, medium, or high medication adherence in accordance with the MMAS-8 scoring criteria (low &#x0003c;6, medium 6&#x0003c;8, and high=8).</p><p>Visit adherence was measured as the percent of patients attending their scheduled postop appointment. Patients who did not keep their scheduled appointment were considered noncompliant. These patients were contacted and asked to return for their follow-up exam and final data collection. Patients who could not be reached or did not return after being contacted were considered &#x0201c;no show.&#x0201d;</p><p>Clinical outcomes measured included best corrected (with refraction) visual acuity measured on a Snellen chart at 6 m, intraocular pressure measured with Goldmann tonometry, and intraocular inflammation graded by standardized uveitis nomenclature based on the number of cells per 1 mm<sup>2</sup> high power field [<xref rid="ref27" ref-type="bibr">27</xref>].</p><p>Responses were categorized into two types: (1) simple acknowledgments (eg, thank you) and questions. The type of media used for response was divided into three groups: sticker or emoji, photo, or text. Questions were subdivided into three types: administrative (eg, appointment or scheduling issue); postop care (eg, medication, dressing, and activity issues); and clinical symptoms requiring triage (eg, discomfort or a change in vision).</p><p>At the POD-30 visit, patients in the message group completed a 3-question feedback questionnaire evaluating their impressions regarding the frequency of messages, the content of messages, and recommendation for use of messages to other postop cataract patients.</p></sec><sec><title>Statistical Analysis</title><p>The demographic characteristics of the patients were summarized as the mean and standard deviation (SD) for continuous variables and as frequency counts with percentages for categorical variables. MMAS-8 scores for low and medium adherence were combined to perform statistical analysis because of low frequency of responses in some categories. The percentage of MMAS-8 low or medium adherence scores was compared with high adherence scores using chi-square or Fishers exact test, depending on response frequency. The association of MMAS-8 score between message and no message groups were presented as odds ratio (OR) and 95% CI and was obtained using multiple logistic regression and generalize estimating equation (GEE). The adjusted OR were obtained in the same manner with the inclusion of gender, age, and LINE user type into the multivariate model.&#x000a0;A <italic>P</italic> value of less than .05 was considered significant. All analyses were performed using Stata (StataCorp) version 13.</p></sec><sec><title>Ethical Issues</title><p>Approval was obtained from the Khon Kaen University Ethics Committee in Human Research. Informed consent was obtained from all study participants. The research adhered to the tenets of the Declaration of Helsinki. The research was compliant with the Health Insurance Portability and Accountability Act.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Demographics</title><p><xref ref-type="table" rid="table1">Table 1</xref> describes the demographics of the study participants. The average age in the message group was 64 versus 68 years in the no message group. Surrogate users of the LINE app was 55% in the message group and 75% in the no message group.</p></sec><sec><title>Medication Adherence</title><p><xref ref-type="table" rid="table2">Table 2</xref> shows data regarding MMAS-8 medication adherence scores at preop, POD-7, and POD-30 in the message and no message groups. Medication adherence was better in the message group at POD-7 (96% vs 73%, <italic>P</italic>=.004), but no statistically significant differences in medication adherence between the groups were noted at preop and POD-30. There were 4 patients from the no message group who did not keep their POD-30 appointment and did not reschedule, so MMAS-8 survey could not be completed. There were no differences in MMAS-8 scores between patient and surrogate smartphone users at preop, POD-7, or POD-30 visits (<xref ref-type="table" rid="table3">Table 3</xref>). The association of MMAS-8 score by message or no message groups at POD-7 adjusted for baseline score, gender, age, and LINE user type (patient vs surrogate) was significant (adjusted OR=8.6; 95% CI 1.7-43.2; <italic>P</italic>=.009), but the overall association of MMAS-8 score between two groups using GEE become nonsignificant (adjusted OR=2.48; 95% CI 0.86-7.18; <italic>P</italic>=.09; <xref ref-type="app" rid="app8">Multimedia Appendix 8</xref>).</p><table-wrap id="table1" position="float"><label>Table 1</label><caption><p>Demographic data and baseline characteristics of study population.</p></caption><table frame="hsides" rules="groups" width="1000" cellpadding="5" cellspacing="0" border="1"><col width="30" span="1"/><col width="550" span="1"/><col width="140" span="1"/><col width="160" span="1"/><col width="120" span="1"/><thead><tr valign="top"><td colspan="2" rowspan="1">Study population characteristics</td><td rowspan="1" colspan="1">Message, n (%)</td><td rowspan="1" colspan="1">No message, n (%)</td><td rowspan="1" colspan="1">Overall, n (%)</td></tr></thead><tbody><tr valign="top"><td colspan="2" rowspan="1">Number of patients</td><td rowspan="1" colspan="1">49 (50)</td><td rowspan="1" colspan="1">49 (50)</td><td rowspan="1" colspan="1">98 (100)</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>Gender</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">25 (51)</td><td rowspan="1" colspan="1">20 (41)</td><td rowspan="1" colspan="1">45 (46)</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">24 (49)</td><td rowspan="1" colspan="1">29 (59)</td><td rowspan="1" colspan="1">53 (54)</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>Age groups (years)</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Less than 65</td><td rowspan="1" colspan="1">28 (57)</td><td rowspan="1" colspan="1">20 (41)</td><td rowspan="1" colspan="1">48 (49)</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">65 and above</td><td rowspan="1" colspan="1">21(43)</td><td rowspan="1" colspan="1">29 (59)</td><td rowspan="1" colspan="1">50 (51)</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>Line user</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Patient</td><td rowspan="1" colspan="1">22 (45)</td><td rowspan="1" colspan="1">12 (25)</td><td rowspan="1" colspan="1">34 (35)</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Surrogate</td><td rowspan="1" colspan="1">27 (55)</td><td rowspan="1" colspan="1">37 (75)</td><td rowspan="1" colspan="1">64 (65)</td></tr></tbody></table></table-wrap><table-wrap id="table2" position="float"><label>Table 2</label><caption><p>Comparison of the 8-item Morisky Medication Adherence Scale (MMAS-8) score in message and no message groups by visit.</p></caption><table frame="hsides" rules="groups" width="1000" cellpadding="5" cellspacing="0" border="1"><col width="30" span="1"/><col width="280" span="1"/><col width="110" span="1"/><col width="140" span="1"/><col width="200" span="1"/><col width="120" span="1"/><col width="120" span="1"/><thead><tr valign="top"><td rowspan="2" colspan="2"><break/>Visit</td><td colspan="4" rowspan="1">MMAS-8<sup>a</sup> score (N=98)</td><td rowspan="1" colspan="1"><italic>P</italic> value<sup>b</sup></td></tr><tr valign="top"><td rowspan="1" colspan="1">Low, n (%)</td><td rowspan="1" colspan="1">Medium, n (%)</td><td rowspan="1" colspan="1">Low and medium, n (%)</td><td rowspan="1" colspan="1">High, n (%)</td><td rowspan="1" colspan="1"><break/></td></tr></thead><tbody><tr valign="top"><td colspan="2" rowspan="1"><bold>Preop</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Message</td><td rowspan="1" colspan="1">18 (36)</td><td rowspan="1" colspan="1">21 (42)</td><td rowspan="1" colspan="1">39 (80)</td><td rowspan="1" colspan="1">10 (20)</td><td rowspan="2" colspan="1">.8<sup>c</sup></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">No message</td><td rowspan="1" colspan="1">22 (44)</td><td rowspan="1" colspan="1">18 (37)</td><td rowspan="1" colspan="1">40 (82)</td><td rowspan="1" colspan="1">9 (18)</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>POD<sup>d</sup></bold><bold>-7</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Message</td><td rowspan="1" colspan="1">1 (2)</td><td rowspan="1" colspan="1">1 (2)</td><td rowspan="1" colspan="1">2 (4)</td><td rowspan="1" colspan="1">47 (96)</td><td rowspan="2" colspan="1">.004<sup>e</sup></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">No message</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">13 (26)</td><td rowspan="1" colspan="1">13 (27)</td><td rowspan="1" colspan="1">36 (73)</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>POD-30</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Message</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">6 (12)</td><td rowspan="1" colspan="1">6 (12)</td><td rowspan="1" colspan="1">43 (88)</td><td rowspan="2" colspan="1">.74<sup>e</sup></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">No message</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">4 (9)</td><td rowspan="1" colspan="1">4 (9)</td><td rowspan="1" colspan="1">41 (91)</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>MMAS-8: 8-item Morisky Medication Adherence Scale.</p></fn><fn id="table2fn2"><p><sup>b</sup><italic>P</italic> value reflects low and medium compared with high.</p></fn><fn id="table2fn3"><p><sup>c</sup><italic>P</italic> value based on chi-square test.</p></fn><fn id="table2fn4"><p><sup>d</sup>POD: postop day.</p></fn><fn id="table2fn5"><p><sup>e</sup><italic>P</italic> value based on Fishers exact test.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table3" position="float"><label>Table 3</label><caption><p>Comparison of the 8-item Morisky Medication Adherence Scale (MMAS-8) score by a LINE user.</p></caption><table frame="hsides" rules="groups" width="1000" cellpadding="5" cellspacing="0" border="1"><col width="30" span="1"/><col width="280" span="1"/><col width="110" span="1"/><col width="140" span="1"/><col width="200" span="1"/><col width="120" span="1"/><col width="120" span="1"/><thead><tr valign="top"><td rowspan="2" colspan="2"><break/>Visit</td><td colspan="4" rowspan="1">MMAS-8<sup>a</sup> score (N=98)</td><td rowspan="1" colspan="1"><italic>P</italic> value<sup>b</sup></td></tr><tr valign="top"><td rowspan="1" colspan="1">Low, n (%)</td><td rowspan="1" colspan="1">Medium, n (%)</td><td rowspan="1" colspan="1">Low and medium, n (%)</td><td rowspan="1" colspan="1">High, n (%)</td><td rowspan="1" colspan="1"><break/></td></tr></thead><tbody><tr valign="top"><td colspan="2" rowspan="1"><bold>Preop</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Patient</td><td rowspan="1" colspan="1">17 (50)</td><td rowspan="1" colspan="1">13 (38)</td><td rowspan="1" colspan="1">30 (88)</td><td rowspan="1" colspan="1">4 (12)</td><td rowspan="2" colspan="1">.19<sup>c</sup></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Surrogate</td><td rowspan="1" colspan="1">23 (36)</td><td rowspan="1" colspan="1">26 (41)</td><td rowspan="1" colspan="1">49 (77)</td><td rowspan="1" colspan="1">15 (23)</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>POD<sup>d</sup></bold><bold>-7</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Patient</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">4 (12)</td><td rowspan="1" colspan="1">4 (12)</td><td rowspan="1" colspan="1">30 (88)</td><td rowspan="2" colspan="1">.57<sup>c</sup></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Surrogate</td><td rowspan="1" colspan="1">1 (2)</td><td rowspan="1" colspan="1">10 (16)</td><td rowspan="1" colspan="1">11 (17)</td><td rowspan="1" colspan="1">53 (83)</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>POD-30</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Patient</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">5 (15)</td><td rowspan="1" colspan="1">5 (15)</td><td rowspan="1" colspan="1">29 (85)</td><td rowspan="2" colspan="1">.34<sup>f</sup></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Surrogate<sup>e</sup></td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">5 (8)</td><td rowspan="1" colspan="1">5 (8)</td><td rowspan="1" colspan="1">55 (92)</td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><p><sup>a</sup>MMAS-8: 8-item Morisky Medication Adherence Scale.</p></fn><fn id="table3fn2"><p><sup>b</sup><italic>P</italic> value reflects low and medium compared with high.</p></fn><fn id="table3fn3"><p><sup>c</sup><italic>P</italic> value based on Fishers exact test.</p></fn><fn id="table3fn4"><p><sup>d</sup>POD: postop day.</p></fn><fn id="table3fn5"><p><sup>e</sup>Four patients in surrogate group did not keep POD-30 follow-up, so MMAS-8 score is not available.</p></fn><fn id="table3fn6"><p><sup>f</sup><italic>P</italic> value based on chi-square test.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Visit Adherence</title><p>Results of visit adherence scores in the message and no message groups at the preop, POD-7, and POD-30 appointments are summarized in <xref ref-type="table" rid="table4">Table 4</xref>. Visit adherence was lower in the no message group at POD-30: (43/49) vs 100% (49/49) in the message group, <italic>P</italic>=.03, but visit adherence was otherwise 100% in each group at each visit time point.</p></sec><sec><title>Clinical Outcomes</title><p><xref ref-type="table" rid="table5">Table 5</xref> shows clinical outcomes at the preop visit, POD-7, and POD-30. Visual acuity was better at POD-7 in the message group (LogMAR acuity 0.19 vs 0.36, <italic>P</italic>=.02) but was not statistically different between groups at preop or POD-30 visits. After adjusting for age, gender, and LINE user type, the difference in visual acuity at POD-7 remained significant (<xref ref-type="app" rid="app9">Multimedia Appendix 9</xref>). Intraocular pressure and intraocular inflammation measurements showed no statistically significant differences between groups at any postop visit.</p></sec><sec><title>Number and Type of Responses to LINE Messages</title><p>Each of the 49 patients in the message group received nine standardized messages, resulting in 441 total messages sent. Of the 49 patients, 41 (84%) responded to at least one message and 5 patients responded to every message. Each message elicited a response by approximately 50% of the recipients.</p><p>Out of 270 total responses, there were 188 (70%) simple acknowledgments such as &#x0201c;thank you&#x0201d; and 82 (30%) questions. Out of 82 question responses, 31 (38%) were about administrative issues (eg, appointments), 28 (34%) about postop care (eg, medications), and 23 (28%) about a clinical symptom (eg, foreign body sensation). All the questions&#x02019; responses about symptoms were triaged by nurses or ophthalmologists and only required patient reassurance or additional information about concerns (<xref ref-type="app" rid="app10">Multimedia Appendix 10</xref>).</p><p>Patients responded to messages using three different media types: stickers or emojis, photos, or typed messages. Out of 270 total responses, 25 (9%) included photographs, usually of a pleasant or happy nonclinical nature. There were 6 (2%, 6/270) patients who sent photos of medication bottles, bandages, or their eye to help explain their question. There were 102 (38%, 102/270) responses using &#x0201c;stickers,&#x0201d; which are colorful, cartoon-like replies similar to emoji&#x02019;s but larger in size to communicate a variety of emotions and feelings such as thankfulness, appreciation, or happiness in the LINE app. A total of 143 responses (53%, 143/270) were a typed message.</p></sec><sec><title>Patient Feedback Regarding LINE Message Frequency and Content</title><p>Out of 49 patients who received messages, all of them completed the feedback survey; 46 (94%) judged the number of messages to be &#x0201c;just right,&#x0201d; and 3 (6%) wanted more messages. None wanted fewer messages. There were 48 (98%, 48/49) patients who found the message content helpful, with 16 (32%, 16/49) rating it &#x0201c;just right,&#x0201d; 20 (40%, 20/49) &#x0201c;helpful,&#x0201d; and 12 (24%, 12/49) &#x0201c;very helpful.&#x0201d; One of 49 patients (2%) thought the message content was slightly helpful.</p><p>There were 39 patients (79%, 39/49) who &#x0201c;recommended&#x0201d; and 7 patients (14%, 7/49) who &#x0201c;strongly recommended&#x0201d; the messages for future cataract surgery patients. There were 3 patients (6%, 3/49) who were &#x0201c;neutral&#x0201d; about recommending the messages to a cataract patient.</p><table-wrap id="table4" position="float"><label>Table 4</label><caption><p>Visit adherence by message and no message groups at preop, POD-7, and POD-30 (Fishers exact test).</p></caption><table frame="hsides" rules="groups" width="1000" cellpadding="5" cellspacing="0" border="1"><col width="30" span="1"/><col width="550" span="1"/><col width="140" span="1"/><col width="160" span="1"/><col width="120" span="1"/><thead><tr valign="top"><td colspan="2" rowspan="1">Visit adherence</td><td rowspan="1" colspan="1">Message, n (%)</td><td rowspan="1" colspan="1">No message, n (%)</td><td rowspan="1" colspan="1"><italic>P</italic> value</td></tr></thead><tbody><tr valign="top"><td colspan="2" rowspan="1"><bold>Preop</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="3" colspan="1">-</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">0 (0)</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">49 (100)</td><td rowspan="1" colspan="1">49 (100)</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>POD<sup>a</sup></bold><bold>-7</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="3" colspan="1">-</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">0 (0)</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">49 (100)</td><td rowspan="1" colspan="1">49 (100)</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>POD-30</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="3" colspan="1">.03<sup>b</sup></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">6<sup>c</sup> (12)</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">49 (100)</td><td rowspan="1" colspan="1">43 (88)</td></tr></tbody></table><table-wrap-foot><fn id="table4fn1"><p><sup>a</sup>POD: postop day.</p></fn><fn id="table4fn2"><p><sup>b</sup>Fishers exact test.</p></fn><fn id="table4fn3"><p><sup>c</sup>Six patients did not keep the scheduled POD-30 appointment; 2 patients later rescheduled.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table5" position="float"><label>Table 5</label><caption><p>Comparison of clinical outcomes between message and no message groups by preop, POD-7, and POD-30 visits.</p></caption><table frame="hsides" rules="groups" width="1000" cellpadding="5" cellspacing="0" border="1"><col width="30" span="1"/><col width="290" span="1"/><col width="140" span="1"/><col width="170" span="1"/><col width="140" span="1"/><col width="120" span="1"/><col width="120" span="1"/><thead><tr valign="top"><td colspan="2" rowspan="1">Clinical</td><td rowspan="1" colspan="1">Message (n=49) Mean (SD<sup>a</sup>)</td><td rowspan="1" colspan="1">No message (n=49) <break/>Mean (SD)</td><td rowspan="1" colspan="1">Mean difference</td><td rowspan="1" colspan="1">95% CI</td><td rowspan="1" colspan="1"><italic>P</italic> value</td></tr></thead><tbody><tr valign="top"><td colspan="2" rowspan="1"><bold>Visual acuity (LogMAR)</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Preop</td><td rowspan="1" colspan="1">0.90 (0.66)</td><td rowspan="1" colspan="1">0.84 (0.55)</td><td rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">&#x02212;0.18 to 0.30</td><td rowspan="1" colspan="1">.63</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">POD<sup>b</sup>-7</td><td rowspan="1" colspan="1">0.19 (0.25)</td><td rowspan="1" colspan="1">0.36 (0.43)</td><td rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1">0.03-0.31</td><td rowspan="1" colspan="1">.02</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">POD-30</td><td rowspan="1" colspan="1">0.19 (0.25)</td><td rowspan="1" colspan="1">0.36 (0.78)</td><td rowspan="1" colspan="1">0.16</td><td rowspan="1" colspan="1">&#x02212;0.07 to 0.40</td><td rowspan="1" colspan="1">.16</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>Intraocular pressure</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Preop</td><td rowspan="1" colspan="1">14.65 (3.77)</td><td rowspan="1" colspan="1">14.27 (3.79)</td><td rowspan="1" colspan="1">0.38</td><td rowspan="1" colspan="1">&#x02212;1.14 to 1.91</td><td rowspan="1" colspan="1">.62</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">POD-7</td><td rowspan="1" colspan="1">11.71 (2.61)</td><td rowspan="1" colspan="1">12.31 (3.09)</td><td rowspan="1" colspan="1">0.59</td><td rowspan="1" colspan="1">&#x02212;0.56 to 1.74</td><td rowspan="1" colspan="1">.31</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">POD-30</td><td rowspan="1" colspan="1">13.16 (3.42)</td><td rowspan="1" colspan="1">12.22 (3.62)</td><td rowspan="1" colspan="1">0.94</td><td rowspan="1" colspan="1">&#x02212;0.50 to 2.38</td><td rowspan="1" colspan="1">.2</td></tr><tr valign="top"><td colspan="2" rowspan="1"><bold>Intraocular inflammation</bold></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">Preop</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1"><break/></td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">POD-7</td><td rowspan="1" colspan="1">0.33 (0.62)</td><td rowspan="1" colspan="1">0.38 (0.53)</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">&#x02212;0.19 to 0.28</td><td rowspan="1" colspan="1">.68</td></tr><tr valign="top"><td rowspan="1" colspan="1"><break/></td><td rowspan="1" colspan="1">POD-30</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">0 (0)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1"><break/></td></tr></tbody></table><table-wrap-foot><fn id="table5fn1"><p><sup>a</sup>SD: standard deviation.</p></fn><fn id="table5fn2"><p><sup>b</sup>POD: postop day.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><sec><title>Principal Findings</title><sec><title>Medication and Visit Adherence</title><p>Our study showed that two-way social media messaging in postop cataract surgical patients was feasible and favorably received by patients. The medication and visit adherence of the postop patients were both generally high and left relatively little room for improvement in the intervention group, and both message and nonmessage groups showed improvement in medication adherence score from their baseline, suggesting that patients are more compliant because of the recent surgery. However, medication adherence measurements in the message group at POD-7 were significantly higher than the nonmessage group, suggesting that messages helped patients remember or understand the importance of taking their medications earlier in the postop process. This is potentially helpful in patients at risk of developing cystoid macular edema (CME). Visit adherence was higher, reaching 100% in the message groups at POD-30. The emphasis on visit adherence in the messages may have helped achieve this and is clinically important as complications such as CME can still develop at this time. Final clinical outcomes were not different between the message and nonmessage groups, but the visual acuity was higher at POD-7. As we did not detect a difference in inflammation levels between the message and no message groups, we suspect that this be because of an unknown confounder or chance.</p></sec><sec><title>Communication Modalities</title><p>Social media smartphone messaging apps allow for a variety of communication modalities, and our patients used many of them. Written text was used most frequently; stickers were nearly as popular. Stickers are a signature feature of the LINE messaging app and are widely used in Thailand. They are increasingly popular features on similar social media apps throughout the world. They offer an element of entertainment and sentiment to users. This is an important consideration as lack of patient engagement has been identified as a key barrier in patient adoption of mHealth technologies [<xref rid="ref28" ref-type="bibr">28</xref>]. The use of photos of the eye, bandages, or medication bottles to help clarify a question was helpful to staff and patients. Ophthalmologists can sometimes benefit from a mobile phone photo of the eye when triaging remotely patients&#x02019; complaints. A mobile phone camera with proper focus and flash illumination can generate a clinically useful image in postop cataract patients [<xref rid="ref29" ref-type="bibr">29</xref>].</p></sec></sec><sec><title>Study Limitations</title><p>Our study has several important limitations. We could not confirm if the messages were received as intended though the rapid response suggested that the messages generally were received. Another weakness is that we did not measure phone calls or unscheduled visits to the clinic in the nonmessage group, which would provide valuable information in assessing the impact of our intervention and changes in workload for the clinic staff. Whereas the patient feedback was generally very positive, we did not design the study to determine the optimal frequency and timing of our messages. As our medication adherence measure was a self-reported survey, we acknowledge that it is subject to social desirability bias. This could result in a higher medication adherence score in patients who are concerned about disappointing their surgeon or other members of their care team. We looked for differences in the message and nonmessage groups for medication adherence and visual acuity with regard to age, gender, and LINE user type using a multivariate analysis (GEE) but found no significant differences regarding number, type, or content of messages. However, we were unable to perform this analysis for visit adherence because visit adherence was 100% in all the message groups.</p></sec><sec><title>Comparison With Prior Work</title><sec><title>Medication and Visit Adherence</title><p>Our study differs from most other medication and visit adherence studies for chronic disease management in that it looked at an mHealth intervention in cataract surgery postop care, which is a short-term, acute, episodic process. Our results support that reminders in this population can also be helpful in improving compliance. This aligns with findings in other ophthalmic reminder studies [<xref rid="ref13" ref-type="bibr">13</xref>-<xref rid="ref17" ref-type="bibr">17</xref>] and postop reminder studies [<xref rid="ref12" ref-type="bibr">12</xref>,<xref rid="ref16" ref-type="bibr">16</xref>,<xref rid="ref17" ref-type="bibr">17</xref>].</p></sec><sec><title>Two-Way Messaging</title><p>Two-way messaging has the potential to create voluminous, unwanted responses by patients resulting in increased workload for physicians and staff. Armstrong et al reported that patients using a postop home monitoring app for breast reconstruction surgery sent more emails to clinic staff in the first 30 days [<xref rid="ref11" ref-type="bibr">11</xref>]. We found clinical symptom questions were similar to those typically seen in routine postop cataract surgery patients and tended to cluster in a small number of patients, similar to the pattern seen in a phone-based system. Many of the questions sent by patients in our study could be easily managed by office and nursing staff, who noted a preference to answering messages on their computer when time permitted rather than receiving phone calls that interrupted workflow throughout the day. Greater convenience and efficiency was also reported when members of an orthopedic care team used a mobile phone messaging app (WhatsApp) for communication [<xref rid="ref30" ref-type="bibr">30</xref>]. Lyu et al found that using WeChat for clinical follow-up of postop head and neck surgical patients in China is more time-efficient than using telephone follow-up [<xref rid="ref31" ref-type="bibr">31</xref>]. In the next iteration of the project, we plan to create a simplified &#x0201c;thank you-my eye is doing well&#x0201d; reply to help reduce the number of acknowledgment responses, which would reduce the workload for staff.</p></sec><sec><title>Future Directions</title><p>The research supporting the use of mobile phone apps throughout the perioperative period is increasing in the preoperative, perioperative, and postop periods [<xref rid="ref32" ref-type="bibr">32</xref>]. Previous research in tele-ophthalmology has demonstrated benefits in screening and remote diagnosis in retinal diseases, glaucoma, pediatric retinopathy, and emergency triage [<xref rid="ref33" ref-type="bibr">33</xref>]. Our study addresses the opportunity for improving compliance with postop care using social messaging in comparison with some of the other most recent research using mHealth in postop care that focus on self-management tools. These include symptoms surveys, wound photos, and educational information [<xref rid="ref11" ref-type="bibr">11</xref>,<xref rid="ref34" ref-type="bibr">34</xref>-<xref rid="ref36" ref-type="bibr">36</xref>]. Incorporating similar tools in our intervention is an area for further development and research.</p><p>To realize the benefits of using social media postop messaging at scale, we see a critical need to develop a robust program to automate messaging for patients at different stages of the postop process and the capacity to adapt these messages for changes in patient management. Other postop studies have incorporated alerts to help automate the monitoring process [<xref rid="ref11" ref-type="bibr">11</xref>,<xref rid="ref12" ref-type="bibr">12</xref>], but this does not eliminate the need for managing outliers and adjustments to a patient&#x02019;s postop care plan. Follow-up with surgeons participating in one postop home monitoring study following questionnaires and photos raised concerns about managing the workload of monitoring patient responses, even without incorporating patient-initiated communications [<xref rid="ref12" ref-type="bibr">12</xref>].</p><p>Another issue requiring further study is to determine the operational impact, including cost and time efficiency of two-way postop messaging. In clinics with a large volume of cataract surgery, this is important information that will ultimately determine uptake of this technology. Low resource settings may not have the option to devote staff to this system unless financial or operational benefits can be demonstrated.</p></sec></sec><sec><title>Conclusions</title><p>Using two-way social media messaging for postop care is a promising innovation for not only cataract surgery but other surgical specialties. In addition to improving medication and visit adherence, our impression was that the patients liked the feeling of safety and connection to their care team provided by repeated messaging.</p></sec></sec></body><back><ack><p>The authors would like to acknowledge the valuable assistance received from Nattadaporn Promchan, Maleewan Anusuriya, and the Khon Kaen University&#x02019;s eye care team in conducting this research.</p><p>They would also like to acknowledge that they have obtained written permission from copyright owners for any excerpts from copyrighted works that are included in the study and have credited the sources in the study or the supplemental materials. Use of the MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, UCLA Fielding School of Public Health.</p></ack><fn-group><fn fn-type="con"><p>Authors' Contributions: TS, KM, and MM developed the research study, collected and analyzed results, and coauthored the manuscript. IA organized the data collection, trained research staff, oversaw initial implementation, and reviewed the manuscript. KT and JT conducted the statistical analysis, produced tables, assisted with the interpretation of results, and reviewed the final manuscript.</p></fn><fn fn-type="COI-statement"><p>Conflicts of Interest: None declared.</p></fn></fn-group><app-group><app id="app1"><title>Multimedia Appendix 1</title><p>Description of pre- and postop cataract surgical care.</p><fig id="d35e1613" position="anchor"><media xlink:href="jmir_v19i12e413_app1.pdf"/></fig></app><app id="app2"><title>Multimedia Appendix 2</title><p>Educational video for patients undergoing cataract surgery: before surgery.</p><fig id="d35e1619" position="anchor"><media xlink:href="jmir_v19i12e413_app2.mp4"/></fig></app><app id="app3"><title>Multimedia Appendix 3</title><p>Educational video for patients undergoing cataract surgery: day of surgery.</p><fig id="d35e1625" position="anchor"><media xlink:href="jmir_v19i12e413_app3.mp4"/></fig></app><app id="app4"><title>Multimedia Appendix 4</title><p>Educational video for patients undergoing cataract surgery: after surgery.</p><fig id="d35e1631" position="anchor"><media xlink:href="jmir_v19i12e413_app4.mp4"/></fig></app><app id="app5"><title>Multimedia Appendix 5</title><p>Educational video for patients undergoing cataract surgery: information for family and caregivers.</p><fig id="d35e1637" position="anchor"><media xlink:href="jmir_v19i12e413_app5.mp4"/></fig></app><app id="app6"><title>Multimedia Appendix 6</title><p>Patient feedback questionnaire regarding LINE messages.</p><fig id="d35e1643" position="anchor"><media xlink:href="jmir_v19i12e413_app6.pdf"/></fig></app><app id="app7"><title>Multimedia Appendix 7</title><p>Morisky Medication Adherence Scale-8 Item questionnaire for postoperative cataract surgery.</p><fig id="d35e1649" position="anchor"><media xlink:href="jmir_v19i12e413_app7.pdf"/></fig></app><app id="app8"><title>Multimedia Appendix 8</title><p>Association of MMAS-8 Score by message or no message groups adjusted for baseline score, gender, age, and LINE user type.</p><fig id="d35e1655" position="anchor"><media xlink:href="jmir_v19i12e413_app8.pdf"/></fig></app><app id="app9"><title>Multimedia Appendix 9</title><p>Association of visual acuity by message or no message groups adjusted for baseline score, gender, age, and LINE user type.</p><fig id="d35e1661" position="anchor"><media xlink:href="jmir_v19i12e413_app9.pdf"/></fig></app><app id="app10"><title>Multimedia Appendix 10</title><p>Message response types and media forms.</p><fig id="d35e1667" position="anchor"><media xlink:href="jmir_v19i12e413_app10.pdf"/></fig></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">CME</term><def><p>cystoid macular edema</p></def></def-item><def-item><term id="abb2">GEE</term><def><p>generalized estimating equation</p></def></def-item><def-item><term id="abb3">mHealth</term><def><p>mobile health</p></def></def-item><def-item><term id="abb4">MMAS-8</term><def><p>8-item Morisky Medication Adherence Scale</p></def></def-item><def-item><term id="abb5">OR</term><def><p>odds ratio</p></def></def-item><def-item><term id="abb6">POD</term><def><p>postop day</p></def></def-item><def-item><term id="abb7">SD</term><def><p>standard deviation</p></def></def-item></def-list></glossary><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labrique</surname><given-names>AB</given-names></name><name><surname>Vasudevan</surname><given-names>L</given-names></name><name><surname>Kochi</surname><given-names>E</given-names></name><name><surname>Fabricant</surname><given-names>R</given-names></name><name><surname>Mehl</surname><given-names>G</given-names></name></person-group><article-title>mHealth innovations as health system strengthening tools: 12 common applications and a visual framework</article-title><source>Glob Health Sci Pract</source><year>2013</year><month>8</month><volume>1</volume><issue>2</issue><fpage>160</fpage><lpage>71</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.ghspjournal.org/cgi/pmidlookup?view=long&#x00026;pmid=25276529"/></comment><pub-id pub-id-type="doi">10.9745/GHSP-D-13-00031</pub-id><pub-id pub-id-type="medline">25276529</pub-id><!--<pub-id pub-id-type="pii">GHSP-D-13-00031</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC4168567</pub-id>--><pub-id pub-id-type="pmid">25276529</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurol-Urganci</surname><given-names>I</given-names></name><name><surname>de</surname><given-names>JT</given-names></name><name><surname>Vodopivec-Jamsek</surname><given-names>V</given-names></name><name><surname>Atun</surname><given-names>R</given-names></name><name><surname>Car</surname><given-names>J</given-names></name></person-group><article-title>Mobile phone messaging reminders for attendance at healthcare appointments</article-title><source>Cochrane Database Syst Rev</source><year>2013</year><issue>12</issue><fpage>CD007458</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD007458.pub3</pub-id><pub-id pub-id-type="medline">24310741</pub-id><pub-id pub-id-type="pmid">24310741</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guy</surname><given-names>R</given-names></name><name><surname>Hocking</surname><given-names>J</given-names></name><name><surname>Wand</surname><given-names>H</given-names></name><name><surname>Stott</surname><given-names>S</given-names></name><name><surname>Ali</surname><given-names>H</given-names></name><name><surname>Kaldor</surname><given-names>J</given-names></name></person-group><article-title>How effective are short message service reminders at increasing clinic attendance? A meta-analysis and systematic review</article-title><source>Health Serv Res</source><year>2012</year><month>4</month><volume>47</volume><issue>2</issue><fpage>614</fpage><lpage>32</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/22091980"/></comment><pub-id pub-id-type="doi">10.1111/j.1475-6773.2011.01342.x</pub-id><pub-id pub-id-type="medline">22091980</pub-id><!--<pub-id pub-id-type="pmcid">PMC3419880</pub-id>--><pub-id pub-id-type="pmid">22091980</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farmer</surname><given-names>T</given-names></name><name><surname>Brook</surname><given-names>G</given-names></name><name><surname>McSorley</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>S</given-names></name><name><surname>Mohamed</surname><given-names>A</given-names></name></person-group><article-title>Using short message service text reminders to reduce 'did not attend' rates in sexual health and HIV appointment clinics</article-title><source>Int J STD AIDS</source><year>2014</year><month>3</month><volume>25</volume><issue>4</issue><fpage>289</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1177/0956462413502325</pub-id><pub-id pub-id-type="medline">23999939</pub-id><!--<pub-id pub-id-type="pii">0956462413502325</pub-id>--><pub-id pub-id-type="pmid">23999939</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabin</surname><given-names>LL</given-names></name><name><surname>Bachman</surname><given-names>DM</given-names></name><name><surname>Gill</surname><given-names>CJ</given-names></name><name><surname>Zhong</surname><given-names>L</given-names></name><name><surname>Vian</surname><given-names>T</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Lan</surname><given-names>G</given-names></name><name><surname>Haberer</surname><given-names>JE</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Gifford</surname><given-names>AL</given-names></name></person-group><article-title>Improving adherence to antiretroviral therapy with triggered real-time text message reminders: the China adherence through technology study</article-title><source>J Acquir Immune Defic Syndr</source><year>2015</year><month>8</month><day>15</day><volume>69</volume><issue>5</issue><fpage>551</fpage><lpage>9</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/25886927"/></comment><pub-id pub-id-type="doi">10.1097/QAI.0000000000000651</pub-id><pub-id pub-id-type="medline">25886927</pub-id><!--<pub-id pub-id-type="pmcid">PMC4552400</pub-id>--><pub-id pub-id-type="pmid">25886927</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mbuagbaw</surname><given-names>L</given-names></name><name><surname>Mursleen</surname><given-names>S</given-names></name><name><surname>Lytvyn</surname><given-names>L</given-names></name><name><surname>Smieja</surname><given-names>M</given-names></name><name><surname>Dolovich</surname><given-names>L</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name></person-group><article-title>Mobile phone text messaging interventions for HIV and other chronic diseases: an overview of systematic reviews and framework for evidence transfer</article-title><source>BMC Health Serv Res</source><year>2015</year><month>1</month><day>22</day><volume>15</volume><fpage>33</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-014-0654-6"/></comment><pub-id pub-id-type="doi">10.1186/s12913-014-0654-6</pub-id><pub-id pub-id-type="medline">25609559</pub-id><!--<pub-id pub-id-type="pii">s12913-014-0654-6</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC4308847</pub-id>--><pub-id pub-id-type="pmid">25609559</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lester</surname><given-names>RT</given-names></name><name><surname>Ritvo</surname><given-names>P</given-names></name><name><surname>Mills</surname><given-names>EJ</given-names></name><name><surname>Kariri</surname><given-names>A</given-names></name><name><surname>Karanja</surname><given-names>S</given-names></name><name><surname>Chung</surname><given-names>MH</given-names></name><name><surname>Jack</surname><given-names>W</given-names></name><name><surname>Habyarimana</surname><given-names>J</given-names></name><name><surname>Sadatsafavi</surname><given-names>M</given-names></name><name><surname>Najafzadeh</surname><given-names>M</given-names></name><name><surname>Marra</surname><given-names>CA</given-names></name><name><surname>Estambale</surname><given-names>B</given-names></name><name><surname>Ngugi</surname><given-names>E</given-names></name><name><surname>Ball</surname><given-names>TB</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name><name><surname>Gelmon</surname><given-names>LJ</given-names></name><name><surname>Kimani</surname><given-names>J</given-names></name><name><surname>Ackers</surname><given-names>M</given-names></name><name><surname>Plummer</surname><given-names>FA</given-names></name></person-group><article-title>Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial</article-title><source>Lancet</source><year>2010</year><month>11</month><day>27</day><volume>376</volume><issue>9755</issue><fpage>1838</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)61997-6</pub-id><pub-id pub-id-type="medline">21071074</pub-id><!--<pub-id pub-id-type="pii">S0140-6736(10)61997-6</pub-id>--><pub-id pub-id-type="pmid">21071074</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wald</surname><given-names>DS</given-names></name><name><surname>Bestwick</surname><given-names>JP</given-names></name><name><surname>Raiman</surname><given-names>L</given-names></name><name><surname>Brendell</surname><given-names>R</given-names></name><name><surname>Wald</surname><given-names>NJ</given-names></name></person-group><article-title>Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial)</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>12</issue><fpage>e114268</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.plos.org/10.1371/journal.pone.0114268"/></comment><pub-id pub-id-type="doi">10.1371/journal.pone.0114268</pub-id><pub-id pub-id-type="medline">25479285</pub-id><!--<pub-id pub-id-type="pii">PONE-D-14-35596</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC4257733</pub-id>--><pub-id pub-id-type="pmid">25479285</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGillicuddy</surname><given-names>JW</given-names></name><name><surname>Gregoski</surname><given-names>MJ</given-names></name><name><surname>Weiland</surname><given-names>AK</given-names></name><name><surname>Rock</surname><given-names>RA</given-names></name><name><surname>Brunner-Jackson</surname><given-names>BM</given-names></name><name><surname>Patel</surname><given-names>SK</given-names></name><name><surname>Thomas</surname><given-names>BS</given-names></name><name><surname>Taber</surname><given-names>DJ</given-names></name><name><surname>Chavin</surname><given-names>KD</given-names></name><name><surname>Baliga</surname><given-names>PK</given-names></name><name><surname>Treiber</surname><given-names>FA</given-names></name></person-group><article-title>Mobile health medication adherence and blood pressure control in renal transplant recipients: a proof-of-concept randomized controlled trial</article-title><source>JMIR Res Protoc</source><year>2013</year><volume>2</volume><issue>2</issue><fpage>e32</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.researchprotocols.org/2013/2/e32/"/></comment><pub-id pub-id-type="doi">10.2196/resprot.2633</pub-id><pub-id pub-id-type="medline">24004517</pub-id><!--<pub-id pub-id-type="pii">v2i2e32</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC3786124</pub-id>--><pub-id pub-id-type="pmid">24004517</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celik</surname><given-names>S</given-names></name><name><surname>Cosansu</surname><given-names>G</given-names></name><name><surname>Erdogan</surname><given-names>S</given-names></name><name><surname>Kahraman</surname><given-names>A</given-names></name><name><surname>Isik</surname><given-names>S</given-names></name><name><surname>Bayrak</surname><given-names>G</given-names></name><name><surname>Bektas</surname><given-names>B</given-names></name><name><surname>Olgun</surname><given-names>N</given-names></name></person-group><article-title>Using mobile phone text messages to improve insulin injection technique and glycaemic control in patients with diabetes mellitus: a multi-centre study in Turkey</article-title><source>J Clin Nurs</source><year>2015</year><month>6</month><volume>24</volume><issue>11-12</issue><fpage>1525</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1111/jocn.12731</pub-id><pub-id pub-id-type="medline">25422134</pub-id><pub-id pub-id-type="pmid">25422134</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>KA</given-names></name><name><surname>Coyte</surname><given-names>PC</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Beber</surname><given-names>B</given-names></name><name><surname>Semple</surname><given-names>JL</given-names></name></person-group><article-title>Effect of home monitoring via mobile app on the number of in-person visits following ambulatory surgery: a randomized clinical trial</article-title><source>JAMA Surg</source><year>2017</year><month>3</month><day>22</day><volume>152</volume><issue>7</issue><fpage>622</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/jamasurg.2017.0111</pub-id><pub-id pub-id-type="medline">28329223</pub-id><!--<pub-id pub-id-type="pii">2612832</pub-id>--><pub-id pub-id-type="pmid">28329223</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semple</surname><given-names>JL</given-names></name><name><surname>Sharpe</surname><given-names>S</given-names></name><name><surname>Murnaghan</surname><given-names>ML</given-names></name><name><surname>Theodoropoulos</surname><given-names>J</given-names></name><name><surname>Metcalfe</surname><given-names>KA</given-names></name></person-group><article-title>Using a mobile app for monitoring post-operative quality of recovery of patients at home: a feasibility study</article-title><source>JMIR mHealth uHealth</source><year>2015</year><volume>3</volume><issue>1</issue><fpage>e18</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://mhealth.jmir.org/2015/1/e18/"/></comment><pub-id pub-id-type="doi">10.2196/mhealth.3929</pub-id><pub-id pub-id-type="medline">25679749</pub-id><!--<pub-id pub-id-type="pii">v3i1e18</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC4342621</pub-id>--><pub-id pub-id-type="pmid">25679749</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyu</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Xiong</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>A</given-names></name><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Lei</surname><given-names>W</given-names></name></person-group><article-title>Smartphone application Wechat for clinical follow-up of discharged patients with head and neck tumors: a randomized controlled trial</article-title><source>Chin Med J (Engl)</source><year>2016</year><month>12</month><day>05</day><volume>129</volume><issue>23</issue><fpage>2816</fpage><lpage>23</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=23;spage=2816;epage=2823;aulast=Lyu"/></comment><pub-id pub-id-type="doi">10.4103/0366-6999.194635</pub-id><pub-id pub-id-type="medline">27900995</pub-id><!--<pub-id pub-id-type="pii">ChinMedJ_2016_129_23_2816_194635</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC5146789</pub-id>--><pub-id pub-id-type="pmid">27900995</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boland</surname><given-names>MV</given-names></name><name><surname>Chang</surname><given-names>DS</given-names></name><name><surname>Frazier</surname><given-names>T</given-names></name><name><surname>Plyler</surname><given-names>R</given-names></name><name><surname>Jefferys</surname><given-names>JL</given-names></name><name><surname>Friedman</surname><given-names>DS</given-names></name></person-group><article-title>Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study</article-title><source>JAMA Ophthalmol</source><year>2014</year><month>7</month><volume>132</volume><issue>7</issue><fpage>845</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1001/jamaophthalmol.2014.857</pub-id><pub-id pub-id-type="medline">24831037</pub-id><!--<pub-id pub-id-type="pii">1871612</pub-id>--><pub-id pub-id-type="pmid">24831037</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brannan</surname><given-names>SO</given-names></name><name><surname>Dewar</surname><given-names>C</given-names></name><name><surname>Taggerty</surname><given-names>L</given-names></name><name><surname>Clark</surname><given-names>S</given-names></name></person-group><article-title>The effect of short messaging service text on non-attendance in a general ophthalmology clinic</article-title><source>Scott Med J</source><year>2011</year><month>8</month><volume>56</volume><issue>3</issue><fpage>148</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1258/smj.2011.011112</pub-id><pub-id pub-id-type="medline">21873719</pub-id><!--<pub-id pub-id-type="pii">56/3/148</pub-id>--><pub-id pub-id-type="pmid">21873719</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koshy</surname><given-names>E</given-names></name><name><surname>Car</surname><given-names>J</given-names></name><name><surname>Majeed</surname><given-names>A</given-names></name></person-group><article-title>Effectiveness of mobile-phone short message service (SMS) reminders for ophthalmology outpatient appointments: observational study</article-title><source>BMC Ophthalmol</source><year>2008</year><month>5</month><day>31</day><volume>8</volume><fpage>9</fpage><comment><ext-link ext-link-type="uri" xlink:href="https://bmcophthalmol.biomedcentral.com/articles/10.1186/1471-2415-8-9"/></comment><pub-id pub-id-type="doi">10.1186/1471-2415-8-9</pub-id><pub-id pub-id-type="medline">18513438</pub-id><!--<pub-id pub-id-type="pii">1471-2415-8-9</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC2438329</pub-id>--><pub-id pub-id-type="pmid">18513438</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Congdon</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Deng</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Effectiveness of a short message reminder in increasing compliance with pediatric cataract treatment: a randomized trial</article-title><source>Ophthalmology</source><year>2012</year><month>12</month><volume>119</volume><issue>12</issue><fpage>2463</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2012.06.046</pub-id><pub-id pub-id-type="medline">22921386</pub-id><!--<pub-id pub-id-type="pii">S0161-6420(12)00606-9</pub-id>--><pub-id pub-id-type="pmid">22921386</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Man</surname><given-names>P</given-names></name><name><surname>Congdon</surname><given-names>N</given-names></name></person-group><article-title>Interventions to promote follow-up after trabeculectomy surgery in rural Southern China: a randomized clinical trial</article-title><source>JAMA Ophthalmol</source><year>2016</year><month>10</month><day>01</day><volume>134</volume><issue>10</issue><fpage>1135</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1001/jamaophthalmol.2016.2819</pub-id><pub-id pub-id-type="medline">27541442</pub-id><!--<pub-id pub-id-type="pii">2543477</pub-id>--><pub-id pub-id-type="pmid">27541442</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aleo</surname><given-names>CL</given-names></name><name><surname>Hark</surname><given-names>L</given-names></name><name><surname>Leiby</surname><given-names>B</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Murchison</surname><given-names>AP</given-names></name><name><surname>Martinez</surname><given-names>P</given-names></name><name><surname>Haller</surname><given-names>JA</given-names></name></person-group><article-title>Ophthalmic patients' utilization of technology and social media: an assessment to improve quality of care</article-title><source>Telemed J E Health</source><year>2014</year><month>10</month><volume>20</volume><issue>10</issue><fpage>887</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1089/tmj.2013.0365</pub-id><pub-id pub-id-type="medline">25188532</pub-id><pub-id pub-id-type="pmid">25188532</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>MA</given-names></name><name><surname>Congdon</surname><given-names>NG</given-names></name><name><surname>Baker</surname><given-names>SK</given-names></name><name><surname>Bloem</surname><given-names>MW</given-names></name><name><surname>Savage</surname><given-names>H</given-names></name><name><surname>Sommer</surname><given-names>A</given-names></name></person-group><article-title>The surgical management of cataract: barriers, best practices and outcomes</article-title><source>Int Ophthalmol</source><year>2008</year><month>8</month><volume>28</volume><issue>4</issue><fpage>247</fpage><lpage>60</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www-ncbi-nlm-nih-gov.ezp-prod1.hul.harvard.edu/pubmed/?term=Sommer%20A%5BAuthor%5D&#x00026;cauthor=true&#x00026;cauthor_uid=17712529"/></comment><pub-id pub-id-type="doi">10.1007/s10792-007-9121-2</pub-id><pub-id pub-id-type="medline">17712529</pub-id><pub-id pub-id-type="pmid">17712529</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brian</surname><given-names>G</given-names></name><name><surname>Taylor</surname><given-names>H</given-names></name></person-group><article-title>Cataract blindness--challenges for the 21st century</article-title><source>Bull World Health Organ</source><year>2001</year><volume>79</volume><issue>3</issue><fpage>249</fpage><lpage>56</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www-ncbi-nlm-nih-gov.ezp-prod1.hul.harvard.edu/pubmed/?term=Taylor%20H%5BAuthor%5D&#x00026;cauthor=true&#x00026;cauthor_uid=11285671"/></comment><pub-id pub-id-type="medline">11285671</pub-id><!--<pub-id pub-id-type="pii">S0042-96862001000300015</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC2566371</pub-id>--><pub-id pub-id-type="pmid">11285671</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morisky</surname><given-names>DE</given-names></name><name><surname>Ang</surname><given-names>A</given-names></name><name><surname>Krousel-Wood</surname><given-names>M</given-names></name><name><surname>Ward</surname><given-names>HJ</given-names></name></person-group><article-title>Predictive validity of a medication adherence measure in an outpatient setting</article-title><source>J Clin Hypertens (Greenwich)</source><year>2008</year><month>5</month><volume>10</volume><issue>5</issue><fpage>348</fpage><lpage>54</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/18453793"/></comment><pub-id pub-id-type="medline">18453793</pub-id><!--<pub-id pub-id-type="pmcid">PMC2562622</pub-id>--><pub-id pub-id-type="pmid">18453793</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakthong</surname><given-names>P</given-names></name><name><surname>Chabunthom</surname><given-names>R</given-names></name><name><surname>Charoenvisuthiwongs</surname><given-names>R</given-names></name></person-group><article-title>Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes</article-title><source>Ann Pharmacother</source><year>2009</year><month>5</month><volume>43</volume><issue>5</issue><fpage>950</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1345/aph.1L453</pub-id><pub-id pub-id-type="medline">19366872</pub-id><!--<pub-id pub-id-type="pii">aph.1L453</pub-id>--><pub-id pub-id-type="pmid">19366872</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tangkiatkumjai</surname><given-names>M</given-names></name><name><surname>Boardman</surname><given-names>H</given-names></name><name><surname>Praditpornsilpa</surname><given-names>K</given-names></name><name><surname>Walker</surname><given-names>DM</given-names></name></person-group><article-title>Prevalence of herbal and dietary supplement usage in Thai outpatients with chronic kidney disease: a cross-sectional survey</article-title><source>BMC Complement Altern Med</source><year>2013</year><month>7</month><day>01</day><volume>13</volume><fpage>153</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www-ncbi-nlm-nih-gov.ezp-prod1.hul.harvard.edu/pubmed/?term=Walker%20DM%5BAuthor%5D&#x00026;cauthor=true&#x00026;cauthor_uid=23815983"/></comment><pub-id pub-id-type="doi">10.1186/1472-6882-13-153</pub-id><pub-id pub-id-type="medline">23815983</pub-id><!--<pub-id pub-id-type="pii">1472-6882-13-153</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC3750602</pub-id>--><pub-id pub-id-type="pmid">23815983</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruanjahn</surname><given-names>G</given-names></name><name><surname>Roberts</surname><given-names>D</given-names></name><name><surname>Monterosso</surname><given-names>L</given-names></name></person-group><article-title>An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand</article-title><source>AIDS Care</source><year>2010</year><month>12</month><volume>22</volume><issue>12</issue><fpage>1555</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1080/09540121003759901</pub-id><pub-id pub-id-type="medline">20582752</pub-id><!--<pub-id pub-id-type="pii">923340111</pub-id>--><pub-id pub-id-type="pmid">20582752</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>La</surname><given-names>CA</given-names></name><name><surname>Cottrell</surname><given-names>N</given-names></name></person-group><article-title>What are validated self-report adherence scales really measuring? A systematic review</article-title><source>Br J Clin Pharmacol</source><year>2014</year><month>3</month><volume>77</volume><issue>3</issue><fpage>427</fpage><lpage>45</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/bcp.12194"/></comment><pub-id pub-id-type="doi">10.1111/bcp.12194</pub-id><pub-id pub-id-type="medline">23803249</pub-id><!--<pub-id pub-id-type="pmcid">PMC3952718</pub-id>--><pub-id pub-id-type="pmid">23803249</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabs</surname><given-names>D</given-names></name><name><surname>Nussenblatt</surname><given-names>R</given-names></name><name><surname>Rosenbaum</surname><given-names>J</given-names></name><collab>Standardization of Uveitis Nomenclature (SUN) Working Group</collab></person-group><article-title>Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop</article-title><source>Am J Ophthalmol</source><year>2005</year><month>9</month><volume>140</volume><issue>3</issue><fpage>509</fpage><lpage>16</lpage><pub-id pub-id-type="medline">16196117</pub-id><!--<pub-id pub-id-type="pii">S0002-9394(05)00407-1</pub-id>--><pub-id pub-id-type="pmid">16196117</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>AR</given-names></name><name><surname>Alore</surname><given-names>EA</given-names></name><name><surname>Naik</surname><given-names>AD</given-names></name><name><surname>Berger</surname><given-names>DH</given-names></name><name><surname>Suliburk</surname><given-names>JW</given-names></name></person-group><article-title>Mixed-methods analysis of factors impacting use of a postoperative mhealth app</article-title><source>JMIR mHealth uHealth</source><year>2017</year><month>2</month><day>08</day><volume>5</volume><issue>2</issue><fpage>e11</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://mhealth.jmir.org/2017/2/e11/"/></comment><pub-id pub-id-type="doi">10.2196/mhealth.6728</pub-id><pub-id pub-id-type="medline">28179215</pub-id><!--<pub-id pub-id-type="pii">v5i2e11</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC5322201</pub-id>--><pub-id pub-id-type="pmid">28179215</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanguansak</surname><given-names>T</given-names></name><name><surname>Morley</surname><given-names>K</given-names></name><name><surname>Morley</surname><given-names>M</given-names></name><name><surname>Kusakul</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Shieh</surname><given-names>E</given-names></name><name><surname>Yospaiboon</surname><given-names>Y</given-names></name><name><surname>Bhoomibunchoo</surname><given-names>C</given-names></name><name><surname>Chai-Ear</surname><given-names>S</given-names></name><name><surname>Joseph</surname><given-names>A</given-names></name><name><surname>Agarwal</surname><given-names>I</given-names></name></person-group><article-title>Comparing smartphone camera adapters in imaging post-operative cataract patients</article-title><source>J Telemed Telecare</source><year>2017</year><month>1</month><volume>23</volume><issue>1</issue><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1177/1357633X15625400</pub-id><pub-id pub-id-type="medline">26851243</pub-id><!--<pub-id pub-id-type="pii">1357633X15625400</pub-id>--><pub-id pub-id-type="pmid">26851243</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellanti</surname><given-names>P</given-names></name><name><surname>Moriarty</surname><given-names>A</given-names></name><name><surname>Coughlan</surname><given-names>F</given-names></name><name><surname>McCarthy</surname><given-names>T</given-names></name></person-group><article-title>The use of Whatsapp smartphone messaging improves communication efficiency within an orthopaedic surgery team</article-title><source>Cureus</source><year>2017</year><month>2</month><day>18</day><volume>9</volume><issue>2</issue><fpage>e1040</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://europepmc.org/abstract/MED/28357172"/></comment><pub-id pub-id-type="doi">10.7759/cureus.1040</pub-id><pub-id pub-id-type="medline">28357172</pub-id><!--<pub-id pub-id-type="pmcid">PMC5356988</pub-id>--><pub-id pub-id-type="pmid">28357172</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyu</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Xiong</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>A</given-names></name><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Lei</surname><given-names>W</given-names></name></person-group><article-title>Smartphone application wechat for clinical follow-up of discharged patients with head and neck tumors: a randomized controlled trial</article-title><source>Chin Med J (Engl)</source><year>2016</year><month>12</month><day>05</day><volume>129</volume><issue>23</issue><fpage>2816</fpage><lpage>23</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=23;spage=2816;epage=2823;aulast=Lyu"/></comment><pub-id pub-id-type="doi">10.4103/0366-6999.194635</pub-id><pub-id pub-id-type="medline">27900995</pub-id><!--<pub-id pub-id-type="pii">ChinMedJ_2016_129_23_2816_194635</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC5146789</pub-id>--><pub-id pub-id-type="pmid">27900995</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpao</surname><given-names>AF</given-names></name><name><surname>Lingappan</surname><given-names>AM</given-names></name><name><surname>Ahumada</surname><given-names>LM</given-names></name><name><surname>Rehman</surname><given-names>MA</given-names></name><name><surname>G&#x000e1;lvez</surname><given-names>JA</given-names></name></person-group><article-title>Perioperative smartphone apps and devices for patient-centered care</article-title><source>J Med Syst</source><year>2015</year><month>9</month><volume>39</volume><issue>9</issue><fpage>102</fpage><pub-id pub-id-type="doi">10.1007/s10916-015-0310-7</pub-id><pub-id pub-id-type="medline">26265239</pub-id><pub-id pub-id-type="pmid">26265239</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sreelatha</surname><given-names>OK</given-names></name><name><surname>Ramesh</surname><given-names>SV</given-names></name></person-group><article-title>Teleophthalmology: improving patient outcomes?</article-title><source>Clin Ophthalmol</source><year>2016</year><volume>10</volume><fpage>285</fpage><lpage>95</lpage><comment><ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.2147/OPTH.S80487"/></comment><pub-id pub-id-type="doi">10.2147/OPTH.S80487</pub-id><pub-id pub-id-type="medline">26929592</pub-id><!--<pub-id pub-id-type="pii">opth-10-285</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC4755429</pub-id>--><pub-id pub-id-type="pmid">26929592</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunter</surname><given-names>R</given-names></name><name><surname>Fernandes-Taylor</surname><given-names>S</given-names></name><name><surname>Mahnke</surname><given-names>A</given-names></name><name><surname>Awoyinka</surname><given-names>L</given-names></name><name><surname>Schroeder</surname><given-names>C</given-names></name><name><surname>Wiseman</surname><given-names>J</given-names></name><name><surname>Sullivan</surname><given-names>S</given-names></name><name><surname>Bennett</surname><given-names>K</given-names></name><name><surname>Greenberg</surname><given-names>C</given-names></name><name><surname>Kent</surname><given-names>KC</given-names></name></person-group><article-title>Evaluating patient usability of an image-based mobile health platform for postoperative wound monitoring</article-title><source>JMIR mHealth uHealth</source><year>2016</year><month>9</month><day>28</day><volume>4</volume><issue>3</issue><fpage>e113</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://mhealth.jmir.org/2016/3/e113/"/></comment><pub-id pub-id-type="doi">10.2196/mhealth.6023</pub-id><pub-id pub-id-type="medline">27683059</pub-id><!--<pub-id pub-id-type="pii">v4i3e113</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC5062001</pub-id>--><pub-id pub-id-type="pmid">27683059</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meij</surname><given-names>E</given-names></name><name><surname>Huirne</surname><given-names>JA</given-names></name><name><surname>Bouwsma</surname><given-names>EV</given-names></name><name><surname>van Dongen</surname><given-names>JM</given-names></name><name><surname>Terwee</surname><given-names>CB</given-names></name><name><surname>van de Ven</surname><given-names>PM</given-names></name><name><surname>den Bakker</surname><given-names>CM</given-names></name><name><surname>van der Meij</surname><given-names>S</given-names></name><name><surname>van Baal</surname><given-names>WM</given-names></name><name><surname>Leclercq</surname><given-names>WK</given-names></name><name><surname>Geomini</surname><given-names>PM</given-names></name><name><surname>Consten</surname><given-names>EC</given-names></name><name><surname>Schraffordt</surname><given-names>KSE</given-names></name><name><surname>van Kesteren</surname><given-names>PJ</given-names></name><name><surname>Stockmann</surname><given-names>HB</given-names></name><name><surname>ten Cate</surname><given-names>AD</given-names></name><name><surname>Davids</surname><given-names>PH</given-names></name><name><surname>Scholten</surname><given-names>PC</given-names></name><name><surname>van den Heuvel</surname><given-names>B</given-names></name><name><surname>Schaafsma</surname><given-names>FG</given-names></name><name><surname>Meijerink</surname><given-names>WJ</given-names></name><name><surname>Bonjer</surname><given-names>HJ</given-names></name><name><surname>Anema</surname><given-names>JR</given-names></name></person-group><article-title>Substitution of usual perioperative care by ehealth to enhance postoperative recovery in patients undergoing general surgical or gynecological procedures: study protocol of a randomized controlled trial</article-title><source>JMIR Res Protoc</source><year>2016</year><month>12</month><day>21</day><volume>5</volume><issue>4</issue><fpage>e245</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.researchprotocols.org/2016/4/e245/"/></comment><pub-id pub-id-type="doi">10.2196/resprot.6580</pub-id><pub-id pub-id-type="medline">28003177</pub-id><!--<pub-id pub-id-type="pii">v5i4e245</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC5215129</pub-id>--><pub-id pub-id-type="pmid">28003177</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGillion</surname><given-names>M</given-names></name><name><surname>Yost</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>A</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><name><surname>Scott</surname><given-names>T</given-names></name><name><surname>Carroll</surname><given-names>S</given-names></name><name><surname>Ritvo</surname><given-names>P</given-names></name><name><surname>Peter</surname><given-names>E</given-names></name><name><surname>Lamy</surname><given-names>A</given-names></name><name><surname>Furze</surname><given-names>G</given-names></name><name><surname>Krull</surname><given-names>K</given-names></name><name><surname>Dunlop</surname><given-names>V</given-names></name><name><surname>Good</surname><given-names>A</given-names></name><name><surname>Dvirnik</surname><given-names>N</given-names></name><name><surname>Bedini</surname><given-names>D</given-names></name><name><surname>Naus</surname><given-names>F</given-names></name><name><surname>Pettit</surname><given-names>S</given-names></name><name><surname>Henry</surname><given-names>S</given-names></name><name><surname>Probst</surname><given-names>C</given-names></name><name><surname>Mills</surname><given-names>J</given-names></name><name><surname>Gossage</surname><given-names>E</given-names></name><name><surname>Travale</surname><given-names>I</given-names></name><name><surname>Duquette</surname><given-names>J</given-names></name><name><surname>Taberner</surname><given-names>C</given-names></name><name><surname>Bhavnani</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>JS</given-names></name><name><surname>Cowan</surname><given-names>D</given-names></name><name><surname>Romeril</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Colella</surname><given-names>T</given-names></name><name><surname>Choini&#x000e8;re</surname><given-names>M</given-names></name><name><surname>Busse</surname><given-names>J</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Victor</surname><given-names>JC</given-names></name><name><surname>Hoch</surname><given-names>J</given-names></name><name><surname>Isaranuwatchai</surname><given-names>W</given-names></name><name><surname>Kaasalainen</surname><given-names>S</given-names></name><name><surname>Ladak</surname><given-names>S</given-names></name><name><surname>O'Keefe-McCarthy</surname><given-names>S</given-names></name><name><surname>Parry</surname><given-names>M</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Stacey</surname><given-names>M</given-names></name><name><surname>Stevens</surname><given-names>B</given-names></name><name><surname>Stremler</surname><given-names>R</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name><name><surname>Watt-Watson</surname><given-names>J</given-names></name><name><surname>Whitlock</surname><given-names>R</given-names></name><name><surname>MacDermid</surname><given-names>JC</given-names></name><name><surname>Leegaard</surname><given-names>M</given-names></name><name><surname>McKelvie</surname><given-names>R</given-names></name><name><surname>Hillmer</surname><given-names>M</given-names></name><name><surname>Cooper</surname><given-names>L</given-names></name><name><surname>Arthur</surname><given-names>G</given-names></name><name><surname>Sider</surname><given-names>K</given-names></name><name><surname>Oliver</surname><given-names>S</given-names></name><name><surname>Boyajian</surname><given-names>K</given-names></name><name><surname>Farrow</surname><given-names>M</given-names></name><name><surname>Lawton</surname><given-names>C</given-names></name><name><surname>Gamble</surname><given-names>D</given-names></name><name><surname>Walsh</surname><given-names>J</given-names></name><name><surname>Field</surname><given-names>M</given-names></name><name><surname>LeFort</surname><given-names>S</given-names></name><name><surname>Clyne</surname><given-names>W</given-names></name><name><surname>Ricupero</surname><given-names>M</given-names></name><name><surname>Poole</surname><given-names>L</given-names></name><name><surname>Russell-Wood</surname><given-names>K</given-names></name><name><surname>Weber</surname><given-names>M</given-names></name><name><surname>McNeil</surname><given-names>J</given-names></name><name><surname>Alpert</surname><given-names>R</given-names></name><name><surname>Sharpe</surname><given-names>S</given-names></name><name><surname>Bhella</surname><given-names>S</given-names></name><name><surname>Mohajer</surname><given-names>D</given-names></name><name><surname>Ponnambalam</surname><given-names>S</given-names></name><name><surname>Lakhani</surname><given-names>N</given-names></name><name><surname>Khan</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name></person-group><article-title>Technology-enabled remote monitoring and self-management -- vision for patient empowerment following cardiac and cascular surgery: user testing and randomized controlled trial protocol</article-title><source>JMIR Res Protoc</source><year>2016</year><month>8</month><day>01</day><volume>5</volume><issue>3</issue><fpage>e149</fpage><comment><ext-link ext-link-type="uri" xlink:href="http://www.researchprotocols.org/2016/3/e149/"/></comment><pub-id pub-id-type="doi">10.2196/resprot.5763</pub-id><pub-id pub-id-type="medline">27480247</pub-id><!--<pub-id pub-id-type="pii">v5i3e149</pub-id>--><!--<pub-id pub-id-type="pmcid">PMC4999307</pub-id>--><pub-id pub-id-type="pmid">27480247</pub-id></element-citation></ref></ref-list></back></article>